167 related articles for article (PubMed ID: 11525028)
1. [Effect of weekly docetaxel in patients with recurrent breast cancer].
Koshizuka K; Serizawa M; Mouri N; Muto S; Takano K; Tada Y; Nakagomi H; Hada M
Gan To Kagaku Ryoho; 2001 Aug; 28(8):1117-20. PubMed ID: 11525028
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of weekly docetaxel therapy for advanced or recurrent breast cancer].
Kuroi K; Bando H; Nagai S; Tanaka C; Hayashi K; Toi M
Gan To Kagaku Ryoho; 2001 Jun; 28(6):797-802. PubMed ID: 11432347
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological study of weekly docetaxel in patients with metastatic breast cancer].
Kim Y; Takatsuka Y; Gotoh K; Hasegawa S; Aritake N; Kan K; Fukunaga M; Touno T; Oozato H; Imamoto H; Yamazaki K; Maruyama H
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1437-41. PubMed ID: 10500531
[TBL] [Abstract][Full Text] [Related]
4. [Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent breast cancer].
Taguchi T; Mori S; Abe R; Hasegawa K; Morishita Y; Tabei T; Sasaki Y; Fujita M; Enomoto K; Hamano K
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2625-32. PubMed ID: 7979423
[TBL] [Abstract][Full Text] [Related]
5. A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer.
Adachi I; Watanabe T; Takashima S; Narabayashi M; Horikoshi N; Aoyama H; Taguchi T
Br J Cancer; 1996 Jan; 73(2):210-6. PubMed ID: 8546908
[TBL] [Abstract][Full Text] [Related]
6. [Clinical efficacy of low-dose weekly docetaxel combined with oral 5'-deoxy-5-fluorouridine (5'-DFUR) in advanced or metastatic breast cancer: a pilot trial].
Harada Y; Ohuchi N; Ohnuki K; Amano G; Yoshida R; Furuta A; Ikegaki H; Kijima G; Satomi S
Gan To Kagaku Ryoho; 2000 Apr; 27(4):579-84. PubMed ID: 10791000
[TBL] [Abstract][Full Text] [Related]
7. Activity and toxicity of docetaxel (Taxotere) in women with previously treated metastatic breast cancer.
Shapiro JD; Millward MJ; Rischin D; Davison JD; Michael M; Francis PA; Ganju V; Toner GC
Aust N Z J Med; 1997 Feb; 27(1):40-4. PubMed ID: 9079252
[TBL] [Abstract][Full Text] [Related]
8. Phase I study of docetaxel administered by bi-weekly infusion to patients with metastatic breast cancer.
Shin E; Ishitobi M; Hiraoia M; Kazumasa F; Hideyuki M; Nishisho I; Toshiro S; Yasunori H; Tosimasa T
Anticancer Res; 2000; 20(6C):4721-6. PubMed ID: 11205207
[TBL] [Abstract][Full Text] [Related]
9. Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer.
Gennari A; Guarneri V; Landucci E; Orlandini C; Rondini M; Salvadori B; Ricci S; Conte PF
Clin Breast Cancer; 2002 Dec; 3(5):346-52. PubMed ID: 12533265
[TBL] [Abstract][Full Text] [Related]
10. A dose escalation study of weekly docetaxel in patients with advanced solid tumors.
Kouroussis C; Agelaki S; Mavroudis D; Souglakos J; Kakolyris S; Kalbakis K; Vardakis N; Reppa D; Hatzidaki D; Samonis G; Georgoulias V
Cancer Chemother Pharmacol; 2000; 46(6):488-92. PubMed ID: 11138462
[TBL] [Abstract][Full Text] [Related]
11. Is weekly docetaxel an active and gentle chemotherapy in the treatment of metastatic breast cancer?
Maisano R; Mare M; Zavettieri M; Caristi N; Mesiti M; Scisca C; La Torre F
Anticancer Res; 2003; 23(2C):1923-6. PubMed ID: 12820480
[TBL] [Abstract][Full Text] [Related]
12. [Low-dose weekly administration of docetaxel for metastatic breast cancer].
Kimijima I; Watanabe T; Sagara H; Ohtake T; Tsuchiya A; Abe R
Gan To Kagaku Ryoho; 1999 Jun; 26(7):995-9. PubMed ID: 10396330
[No Abstract] [Full Text] [Related]
13. [Weekly administration of low-dose paclitaxel for advanced or metastatic breast cancer].
Uno Y; Hirano M; Murakami N; Kikuchi T; Nozawa H; Okuda T; Oya J; Kikkawa H
Gan To Kagaku Ryoho; 2002 Feb; 29(2):227-32. PubMed ID: 11865628
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy and safety of weekly taxol (TXL) for advanced recurrent breast cancer evaluated in a multi-center cooperative clinical trial].
Nishi T; Yamanaka E; Yamasaki M; Tanaka H; Takeda C; Ikeda N; Hoashi T; Higaki J; Matsunami T; Nakano K; Kogire M; Furukawa J; Inui N; Yamauchi E; Takagaki K; Ogino N; Nomura T; Yamada S; Fujimoto M; Uenishi M; Yayoi E;
Gan To Kagaku Ryoho; 2004 Jun; 31(6):897-901. PubMed ID: 15222108
[TBL] [Abstract][Full Text] [Related]
15. Weekly docetaxel as second-line therapy for patients with advanced breast cancer resistant to previous anthracycline treatment.
Ramos M; González-Ageitos A; Amenedo M; González-Quintas A; Gamazo JL; Togores P; Losada G; Almanza C; Romero C; Gómez-Martín C
J Chemother; 2003 Apr; 15(2):192-7. PubMed ID: 12797398
[TBL] [Abstract][Full Text] [Related]
16. [Bi-weekly chemotherapy with medium-dose docetaxel for advanced and recurrent breast cancers (The 15th study of Keiji Breast Cancer Study Group)].
Fujino S; Kan N; Lee CJ; Inamoto T; Mise K; Sawai S; Okamoto M; Nishimura S; Hori T; Maruhashi K; Yamauchi A; Fujii K; Mitsumori M; Higashide S; Takemoto Y; Okamura T;
Gan To Kagaku Ryoho; 2005 May; 32(5):631-5. PubMed ID: 15918562
[TBL] [Abstract][Full Text] [Related]
17. Docetaxel administered on a weekly basis for metastatic breast cancer.
Burstein HJ; Manola J; Younger J; Parker LM; Bunnell CA; Scheib R; Matulonis UA; Garber JE; Clarke KD; Shulman LN; Winer EP
J Clin Oncol; 2000 Mar; 18(6):1212-9. PubMed ID: 10715290
[TBL] [Abstract][Full Text] [Related]
18. [An early phase II clinical study of RP56976 (docetaxel) in patients with breast cancer].
Taguchi T; Hirata K; Kunii Y; Tabei T; Suwa T; Kitajima M; Adachi I; Tominaga T; Shimada H; Sano M
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2453-60. PubMed ID: 7944491
[TBL] [Abstract][Full Text] [Related]
19. Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer.
Hainsworth JD; Burris HA; Erland JB; Thomas M; Greco FA
J Clin Oncol; 1998 Jun; 16(6):2164-8. PubMed ID: 9626217
[TBL] [Abstract][Full Text] [Related]
20. [A phase I study of docetaxel (TXT) and doxifluridine (5'-DFUR) combination therapy in patients with advanced and recurrent breast cancer].
Tominaga T; Nishimura R; Aoyama H; Iwase H; Mitsuyama S; Asaga T; Kimura M;
Gan To Kagaku Ryoho; 2001 Jul; 28(7):965-72. PubMed ID: 11478146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
